Illinois becomes third state to restrict use of artificial intelligence in mental health industry as experts warn about ‘AI psychosis'
The 'Therapy Resources Oversight' legislation prohibits licensed mental health professionals in Illinois from using AI for treatment decisions or communication with clients. It also bans companies from recommending chatbot therapy tools as a be-all alternative to traditional therapy.
5 Illinois became the third state to pass a bill banning therapists from relying on artificial intelligence.
terovesalainen – stock.adobe.com
Advertisement
Enforcement of the bill will rely on complaints from the public that the Illinois Department of Financial and Professional Regulation will investigate. Anyone determined to be violating the ban could face a civil penalty of up to $10,000, according to the legislation text.
Utah and Nevada, two Republican-run states, previously passed similar laws limiting AI's capacity in mental health services in May and late June, respectively.
Unregulated chatbots can take harmless conversations in any direction, sometimes incidentally leading people into divulging sensitive information or pushing people who are already in vulnerable situations to do something drastic, like take their own life, experts have warned.
Advertisement
A Stanford University study released in June found that many chatbots, which are programmed to respond enthusiastically to users, fail to sidestep concerning prompts — including requests for high bridges in specific locations to jump off of.
5 Utah and Nevada previously passed similar bans limiting AI.
AnnaStills – stock.adobe.com
Whereas chatbots affirm unequivocally regardless of the circumstance, therapists provide support and the means to help their patients improve, Vaile Wright, senior director for the office of health care innovation at the American Psychological Association, told the Washington Post.
'Therapists are validating, but it's also our job to point out when somebody is engaging in unhealthy thoughts, feelings, behaviors and then help somebody challenge those and find better options,' Wright told the outlet.
Advertisement
5 Experts warn that overreliance on AI is creating 'psychosis' for heavy users.
Ascannio – stock.adobe.com
The bans, though, are difficult to effectively enforce — and can't prevent everyday people from turning to AI for mental health assistance on their own.
New research released in early August found that many bots like ChatGPT are inducing 'AI psychosis' in unwitting users with no history of mental illnesses.
5 Some chatbots have allegedly contributed to users' suicide attempts.
PhotoGranary – stock.adobe.com
Advertisement
Roughly 75% of Americans have used some form of AI in the last six months, with 33% reporting daily usage for anything from help on homework to desperate romantic connections. This deep engagement is breeding psychological distress in heavy users, according to the digital marketing study.
Many youth, in particular, are falling down the chatbot rabbit hole and turning to machines to supplement human interaction.
5 Roughly 75% of Americans have used AI in some capacity over the last six months, according to one study.
Vane Nunes – stock.adobe.com
Character.Ai, a popular platform where users can create and share chatbots usually based on fictional characters, had to place a warning clarifying that anything the bots say 'should not be relied upon as fact or advice' after a Florida teen fell in love with his 'Game of Thrones' AI character and took his own life.
The platform is still dealing with a lawsuit filed against the company for the teen's death. Despite repeated attempts to dismiss it on First Amendment grounds, a federal judge ruled that the suit could move forward in August.
Another Texas family sued Character.Ai after a chatbot on the app named 'Shonie' encouraged their autistic son to cut himself.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
15 minutes ago
- Yahoo
Guys, Read this Before You Quit Therapy
Finally, you're off the waitlist and it's time for your first therapy appointment. You walk into the office (or log in to Zoom). T-minus 60 minutes until you're totally transformed: anxiety gone, depression a thing of the past, and burnout cured. At least that's what you're expecting to happen. But halfway into your appointment, you're so over hearing, 'Tell me more,' or 'That's quite an experience.' Your (not-so-cheap) therapist sounds a lot like AI, and you wonder: Am I wasting my time? It makes sense why guys are turning to AI for their mental health fix. Some of my patients admit that they prefer to 'talk it out' with Chat GPT; it's not pricey and the algorithm that serves up phrases like 'good job with that' feels weirdly validating (more about that in a bit). Other guys are quitting therapy altogether, choosing to get their emotional support from a traditional human friend. It's normal for the first few sessions to feel pretty useless, but before you bail on therapy, here's what you should know. Therapy Is a Relationship That's right, like any other relationship—a friend, romantic partner, or colleague in the office—you and your therapist need to get to know each other. Sometimes that happens more quickly than others. One of the most common mistakes is quitting therapy because you don't feel comfortable right away. Usually, the first few sessions utilize a technique called 'supportive psychotherapy.' It's when your therapist encourages you through difficult times, with phrases like, 'You're doing a great job,' and makes reflective statements like, 'That must have been tough for you—talk to me about what you were feeling.' As therapists, we do this to prompt our patients to take the session in any direction they think is meaningful. Doing this can help us understand the important areas we will need to focus our future conversations on. Your therapist will want to know what makes you tick, what you are passionate about, and what your treatment goals are. It might feel more awkward than a date or an appointment with your barber because you're not there to impress anyone but to show the 'real you' right from the start. During the first few appointments, therapists often tell you a little about themselves, like if they enjoy running marathons, to help make opening up a little easier. Other times, therapists take more of an observational approach and don't disclose much personal information at all. If this makes you uncomfortable, it's ok to ask your therapist general questions like 'How long have you been practicing,' or 'Where are you from?' to feel that the conversation is just that—a conversation, not a monologue. Therapy Takes Time to Work Think of your first therapy session like the first day of class when you were a kid. It can be exciting, scary, and fun—all in the same day. If you leave your first appointment feeling like you just wasted an hour, I recommend giving it a least a month or two before calling it quits. The amount of time spent in the 'getting to know you' phase can vary depending on how often your sessions are scheduled and how quickly you establish therapeutic alliance, meaning you feel comfortable 'peeling back' your emotional layers in a way that's sincere and transparent. Research shows that after you have a good therapeutic alliance, therapy may even work better. That's when your therapist may pivot toward more specialized therapies like cognitive behavioral therapy (CBT) for depression and anxiety, or cognitive processing therapy (CPT) for trauma. These techniques can be very effective, but they take time to work. CBT can take anywhere from a few sessions to several months to start working. CPT usually consists of weekly sessions for 12 weeks to treat post-traumatic stress disorder (PTSD). If you're interested in Freudian psychoanalysis, where you're likely diving deeply into how childhood experiences shape how you navigate the world today, buckle up, because some studies indicate that the average length of treatment is between 3 and 7 years. Therapy is a journey of self-discovery, and the first few sessions are usually only the beginning. Therapy Is Hard Let me begin by saying that I personally 'get' how hard therapy can be. A few years ago, I went to therapy—not as a psychiatrist, but as a patient. At that time, I was going through a divorce and experiencing some intense panic attacks. My therapist was great (and extremely patient). She even humored me on those rare occasions when I'd interrupt her advice to quip, 'I already understand CBT, that's not going to work.' Then one day, during our third or fourth session, I found myself crying so unconsolably that I could barely get a word out. It was like every emotion I had experienced—good or bad—for almost the past decade was pouring over a broken dam as I sat there bemused by what was happening to me while my tears flooded her couch. Therapy has a way of doing this to you. For some guys—including me—opening up about real feelings, perhaps things you've never shared with anyone else, can be embarrassing and make you feel like you shouldn't go back. Being on the 'other side,' I had seen this take place in my own patients enough times to know that even though I didn't want to go back to therapy, I needed to go back. After that good cry, when I returned to therapy the following week, my therapist wanted to talk about what happened the week before. The fact that she seemed comfortable, helped me feel more comfortable about sharing my feelings. Eventually, I began to leave therapy feeling like a weight was lifted—and that's when I knew that therapy was working for me. Therapy is hard stuff, but it can be well worth it. Although the first few sessions can feel like a waste, they are helping form a good foundation for what's to come. Change takes time, but if you're wanting to 'get to the meat' faster, tell your therapist if there's a topic you would like to discuss at your next appointment. I can recall several of my own patients asking me if we could dive into more structured therapy techniques, such as CBT, as soon as their second appointment. It's an easy pivot, and therapists can always come back to supportive psychotherapy when they need to. Keep in mind that sometimes a certain therapist just isn't a good fit, and that's ok. If after a few sessions, you're not really into your therapists' guided breathwork sessions or detailed interpretations about your childhood, let your therapist know. We are trained to have all types of conversations—even the awkward ones. Before you ditch your therapist for an app, bot, or best pal, ask your therapist about anything you'd like to discuss. If they can't help, they'll probably point you to another mental health professional who can. You Might Also Like The Best Hair Growth Shampoos for Men to Buy Now 25 Vegetables That Are Surprising Sources of Protein
Yahoo
21 minutes ago
- Yahoo
Lilly to hike UK price of Mounjaro weight-loss drug by 170%
By Maggie Fick SEATTLE (Reuters) -Eli Lilly will raise the UK list price of its weight-loss treatment Mounjaro by up to 170%, it said on Thursday, amid a White House push to get drugmakers to raise medicine prices in Europe to allow for price cuts in the United States. The new price, which also applies to Lilly's type 2 diabetes medicine that has the same name, is effective from September. The price for a month's supply of the highest dose of the medicine will increase from £122 to £330, Lilly said. The higher price will affect those who pay for Mounjaro privately, but will not affect those prescribed the medicine through the British public healthcare system, which has a separate deal, a Lilly spokesperson said. The U.S. drugmaker said that when it launched Mounjaro in Britain it agreed to a list price "significantly below" that in its three other European markets to prevent delays in availability through Britain's National Health Service (NHS). "We are now aligning the list price more consistently," Lilly said. The move reflects how the pharmaceutical industry is navigating policy changes in the United States, by far its most lucrative market, where President Donald Trump is pushing for lower domestic prices and encouraging price hikes overseas. Last week Eli Lilly CEO David Ricks told an investor call that parity between U.S. and European drug pricing was desirable in the long run, though he warned that European governments "are not signing up to pay more for drugs". The U.S. pays more for prescription drugs than any other country, often nearly three times as much as other developed nations. Trump says he wants to narrow this gap to stop Americans from being "ripped off." Reuters reported last week that the Trump administration has been talking to drugmakers about ways to level the playing field for medicine prices. A list price is set by the drug manufacturer before any rebates or discounts. Lilly said it was working with private UK healthcare providers, such as online pharmacies, who can set their own prices, to ensure continued access to the medicines. Lilly launched Mounjaro in the UK in February last year, while rival Novo Nordisk's Wegovy treatment has been available in the country since September 2023.
Business Wire
32 minutes ago
- Business Wire
Philips Announces Plan for More Than USD 150 Million of New Investment in Manufacturing and R&D in the U.S. to Expand Production of AI-powered Health Technology Innovations
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Philips, a global leader in health technology, today announced a plan for new investments of more than USD 150 million in U.S. manufacturing and research and development (R&D). As part of today's announcement, Philips unveiled the expansion of its Reedsville, PA, manufacturing facility, which produces AI-enabled ultrasound systems for hospitals across the U.S. These investments come on top of Philips' annual USD 900 million R&D investment in the U.S. as well as investments in nearly 17,000 colleagues across 40 facilities in the United States. Philips has employees in every U.S. state supporting innovations used by clinicians and patients in 90% of hospitals across the country. The investment announced today by Philips includes the expansion of its Reedsville, PA, site and the recently announced expansion of Philips' Image Guided Therapy facility in Plymouth, MN. It also includes additional manufacturing and R&D projects which will come over the next several years to support the company's growth in the U.S. The Reedsville site, which currently manufactures transducers, will also customize the software and configurations of ultrasound systems for specific clinical procedures in cardiovascular, general and maternal care following the expansion. As an example, Philips' industry-leading CV ultrasound platform delivers advanced tools to help doctors diagnose structural heart and coronary artery disease quickly and confidently [1]. 'The proposed planned expansion of our manufacturing facilities is a demonstration of our deep commitment to the U.S. region,' said Jeff DiLullo, Chief Region Leader, Philips North America. 'Each year, Philips spends $900 million in R&D in the U.S. to drive innovation and deliver cutting-edge technology that empowers healthcare professionals to diagnose, treat and monitor patients more effectively. Increasing our manufacturing and R&D capabilities will create jobs and accelerate our ability to deliver better care for more people with innovative AI-enabled solutions.' The expansion of the Reedsville site is expected to add 24,000 square feet of manufacturing space in addition to 40,000 square feet of warehouse space and is expected to create 120 skilled manufacturing jobs. The recently announced expansion of Philips' image-guided therapy facility in Plymouth, MN, which includes the construction of a new medtech training center, is expected to create over 150 new jobs. [1] Philips ultrasound: The next dimension in echocardiography About Royal Philips Royal Philips (NYSE: PHG, AEX: PHIA) is a leading health technology company focused on improving people's health and well-being through meaningful innovation. Philips' patient- and people-centric innovation leverages advanced technology and deep clinical and consumer insights to deliver personal health solutions for consumers and professional health solutions for healthcare providers and their patients in the hospital and the home. Headquartered in the Netherlands, the company is a leader in diagnostic imaging, ultrasound, image-guided therapy, monitoring and enterprise informatics, as well as in personal health. Philips generated 2024 sales of EUR 18 billion and employs approximately 67,300 employees with sales and services in more than 100 countries. News about Philips can be found at Forward-looking statements and other important information This release contains certain forward-looking statements with respect to the financial condition, results of operations and business of Philips and certain of the plans and objectives of Philips with respect to these items. Examples of forward-looking statements include statements made about the strategy, estimates of sales growth, future EBITA, future developments in Philips' organic business and the completion of acquisitions and divestments. By their nature, these statements involve risk and uncertainty because they relate to future events and circumstances and there are many factors that could cause actual results and developments to differ materially from those expressed or implied by these statements. This press release contains inside information within the meaning of Article 7(1) of the EU Market Abuse Regulation.
